This memorandum directs implementation of the Military Health System (MHS) governance reform outlined in my memorandum of March 2, 2012, "Planning for Reform of the Governance of the Military Health System," and affirmed by section 731 ofthe National Defense Authorization Act for FY 2013.

Tuberculosis Control Program

The attached document contains the Department of Defense Uniform Business Office Revised Fiscal Year (FY) 2013 Direct Care Inpatient Billing Rates.

In order to facilitate the expansion of telemedicine services in the Military Health System, this memorandum waives selective provisions of Department of Defense 602S.13-R, "Clinical Quality Assurance in the Military Health System," June 11 , 2004. This waiver is conditioned on the specific provisions of this memorandum, and shall remain in effect, ...

To establish Navy Medicine policy regarding the use of the human papilloma virus (HPV) vaccines in the Navy and Marine Corps.

Medical Planning and Programming Lexicon

Use of Vaccine Loss Report on ASIMS Web

This memorandum clarifies the procedures under title 32 of the Code of Federal Regulations, section 199.24(d)(3) for suspending TRICARE Reserve Select (TRS) coverage for up to 12 months and, upon request from a TRS member/survivor request, lifting the suspension, which will reinstate coverage with no break.

Calendar Year 2013 premium rates are established for TRICARE Reserve Select and TRICARE Retired Reserve as specified in the memorandum.

Calendar Year 2013 premium rates established for the TRICARE Young Adult program as specified in the memorandum.

Announcement of the release of the Military Health System (MHS) Enterprise Architecture (EA) Guide. The guide supports the MHS CIO’s responsibilities for development and maintenance of EA, which complies with the Department of Defense’s responsibilities under the Clinger-Cohen Act of 1996, Public Law 104-106.

This memorandum requests the Services resource a Human Cell, Tissue, and Cellular and Tissue Based Products (HCT/Ps) Program that complies with regulatory standards for management and oversight of HCT/Ps, according to the best fit for their Service.

This Memorandum announces the HIPAA Privacy (6025.18-R) and Security (8580.02-R) for DHA who is responsible for the development and implementation of policies and procedures required under each set of regulations.